Diagnostic Accuracy of Lung Ultrasound for Pneumonia Diagnosis in Children
LUS
Evaluation of Diagnostic Benefit and Feasibility of Using Lung Ultrasound to Diagnose Childhood Pneumonia in Low-resource Settings
1 other identifier
interventional
320
1 country
1
Brief Summary
Chest X-ray is historically being used as an imaging standard to aid to the diagnosis of childhood pneumonia, however, the evidence does not support it as a perfect imaging tool. As an alternative to CXR, lung ultrasound (LUS) could be used as the imaging of choice in children and studies have demonstrated its good accuracy to diagnose childhood pneumonia. However, most diagnostic studies have used CXR as a reference standard. In absence of a 'gold standard' approach, there is a risk that large proportion of children with pneumonia and severe pneumonia could be 'missed' if clinicians relied on LUS only. This research aims to evaluate the diagnostic benefit of LUS in children compared against 'gold standard' diagnosis which is derived based on the clinical information, imaging and laboratory investigations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 19, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2025
CompletedFirst Submitted
Initial submission to the registry
December 16, 2025
CompletedFirst Posted
Study publicly available on registry
January 9, 2026
CompletedJanuary 9, 2026
December 1, 2025
6 months
December 16, 2025
December 30, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Pneumonia missed by LUS
Proportion of children with any pneumonia (severe or non-severe) that would be missed by LUS at initial presentation
From enrolment until day-5 follow up
Pneumonia missed by CXR
Proportion of children with any pneumonia (severe or non-severe) that would be missed by CXR at initial presentation
From enrolment until day-5 follow up
Secondary Outcomes (2)
Diagnostic accuracy of LUS
From enrolment to day-5 follow up
Diagnostic accuracy of CXR
From enrolment to day-5 follow up
Other Outcomes (1)
Proportion of 'missed pneumonia' cases with adverse clinical outcomes
From day of enrolment to day-5 follow up
Study Arms (1)
Chest imaging
EXPERIMENTALSingle arm study that evaluates the role of LUS in diagnosing pneumonia in children. All participants receive LUS scans followed by CXR as chest imaging intervention.
Interventions
Each study participant receives LUS scan followed by CXR as chest imaging modality. LUS is the diagnostic test under investigation, compared against clinical gold standard (described later).
Eligibility Criteria
You may qualify if:
- Clinical suspicion of pneumonia. Pneumonia is suspected in a child meeting the WHO case definition of pneumonia, i.e. cough or difficulty breathing associated with fast breathing and/ or lower chest wall indrawing.
You may not qualify if:
- Non-consenting parents.
- Children who are hospitalized for more than 24 hours.
- Children treated for pneumonia at the study site within past 4 weeks.
- Critical patients requiring emergency lifesaving support and parents unable to cooperate to provide consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Siddhi Memorial Hospital
Bhaktapur, Bagmati, Nepal
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Suraj Bhattarai, MBBS, MSc, DTM&H
London School of Hygiene and Tropical Medicine/ Nagasaki University School of Tropical Medicine and Global Health
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- Care provider performing LUS scans are masked of CXR report and clinical information about he participant, other than the case has WHO defined pneumonia
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research fellow (WISE programme)
Study Record Dates
First Submitted
December 16, 2025
First Posted
January 9, 2026
Study Start
November 19, 2024
Primary Completion
May 15, 2025
Study Completion
June 30, 2025
Last Updated
January 9, 2026
Record last verified: 2025-12